ENTITY
SK Bioscience

SK Bioscience (302440 KS)

165
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
08 Dec 2021 07:54

LG Energy Solution IPO Preview

LG Energy Solution is getting ready to complete its IPO in the Korean stock market on 27 January 2022. This is the biggest ever IPO in Korea.

Logo
326 Views
Share
05 Dec 2021 05:18

2022 Major IPOs Pipeline in Korea

This is our 7th "Annual Edition of the Major Korean IPOs Pipeline Preview" at Smartkarma! This insight will feature 50 of the biggest IPOs in Korea...

Logo
384 Views
Share
02 Dec 2021 19:34

The Big Divergence in COVID-19 Cases in South Korea and Japan: Data, Miracle, & Mystery

In this insight, we discuss the big divergence in COVID-19 cases in South Korean and Japan in the past several months. There has been a MIRACLE of...

Logo
264 Views
Share
bullishSK Bioscience
24 Nov 2021 13:27

KOSPI 200 December Rebalancing: Constituents with a Substantial Free Float Change

KOSPI 200 rebalancing next month should feature a total of 12 constituents having a ±5%p free float change: eight members with +5%p or greater and...

Logo
321 Views
Share
bullishKakaopay
21 Oct 2021 18:27

Kakao Pay Book Building Results

Maeil Business Daily reported after the market close today that Kakao Pay has successfully completed its IPO book building with the IPO price of...

Logo
333 Views
Share
x